Skip to content
DraconiticResearch
Search Sources API
201,683 studies31 sourcesUpdated 30 min ago
PreprintCC0medRxiv

Estimating the Direct Impact of Influenza Vaccination and Vaccine-Averted Illnesses Using an Extended Static Compartmental Model

  • Y. M. Yoo1
  • A. N. Chard
  • J. H. Jara
  • M. A. Rolfes
  • P. Couto
  • F. Nogareda
  • L. M. Duca
  • S. Tempia
  1. 1US Centers for Disease Control and Prevention
Read full textPDFDOICite

Abstract

A previously developed static compartment model informed influenza program decisions by estimating the direct impact of influenza vaccination. To improve the estimation of the burden averted by vaccination, we extended this model to consider multiple influenza seasons, allow natural and vaccine-induced immunity to wane over time allow influenza vaccine effectiveness (VE) to differ by hospitalized versus non-hospitalized influenza-associated illness, and measure deaths averted. For model demonstration, we created a synthetic Northern Hemisphere-like and year-round influenza activity dataset spanning four seasons among older adults (>65 years) and assumed VE against symptomatic illness of 37% (17%-53%) and VE against hospitalization of 45% (28%-59%). Under Northern Hemisphere-like activity and an existing vaccination program with an average annual vaccine coverage of 33%, vaccination averted 15.1% (95% UI: 12.2%-16.3%) of influenza-associated illnesses across four seasons; the annual prevented fraction for hospitalized deaths ranged from 14.4% (95% UI: 11.7%-16.8%) to 18.5% (95% UI: 14.9%-21.5%). Under a hypothetical year round vaccination program with an annual coverage of 20%, vaccination averted 4.9% (95% UI: 3.8%-5.4%) of influenza-associated illnesses across four seasons; the annual prevented fraction for hospitalized deaths ranged from 5.5% (95% UI: 4.3%-6.5%) and 5.8% (95% UI: 4.8%-6.6%). These model extensions allow estimation of vaccine-averted burden across multiple seasons and diverse vaccination program settings, providing information to support influenza vaccination decision-making.

Related

  1. A compartmental model for leptospirosis disease control via vaccination and chlorination
    Abinesh Alagesan, Gunasundari Chandrasekar
    Scientific ReportsPeer-reviewedCC BY 4.0Full textEpidemiology & public healthCrossref
  2. Using Over-the-Counter Retail Medication Sales to Detect and Track Influenza-Like Illnesses Including Novel Diseases: Surveillance Modeling Study.
    Ye Ye, Jessi Espino, John M Aronis +3
    JMIR public health and surveillancePeer-reviewedCC BYFull textEpidemiology & public healthEurope PMC
  3. Estimating the Range and Duration of Post-influenza Symptoms, Conditions, and Diseases
    Open forum infectious diseasesPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. Determinants of influenza vaccination during the 2021/2022 influenza season in the United States: interactive roles of immunosuppression, cancer diagnosis, and healthcare access barriers
    Oluwatobi Emmanuel Adegbile, Kehinde Kazeem Kanmodi, Oluwamisimi Mary Abib +1
    BMC Public HealthPeer-reviewedCC BY-NC-ND 4.0Epidemiology & public healthCrossref
  5. A multidisciplinary consensus report on approach to adult influenza in primary care: Diagnosis, treatment, prevention of complications and vaccination
    Güzin Zeren Öztürk, Meltem Taşbakan, Mine Adaş +2
    Turkish Journal of Family PracticePeer-reviewedCC BYFull textEpidemiology & public healthDOAJ

Cite

BibTeXRIS
BibTeX
@misc{yoo2026estimating,
  title = {{Estimating the Direct Impact of Influenza Vaccination and Vaccine-Averted Illnesses Using an Extended Static Compartmental Model}},
  author = {Y. M. Yoo and A. N. Chard and J. H. Jara and M. A. Rolfes and P. Couto and F. Nogareda and L. M. Duca and S. Tempia},
  howpublished = {medRxiv},
  year = {2026},
  month = oct,
  doi = {10.64898/2026.10.23.26366241},
  url = {https://www.medrxiv.org/content/10.64898/2026.10.23.26366241v1},
  note = {CC0},
}
RIS
TY  - UNPB
TI  - Estimating the Direct Impact of Influenza Vaccination and Vaccine-Averted Illnesses Using an Extended Static Compartmental Model
AU  - Y. M. Yoo
AU  - A. N. Chard
AU  - J. H. Jara
AU  - M. A. Rolfes
AU  - P. Couto
AU  - F. Nogareda
AU  - L. M. Duca
AU  - S. Tempia
PY  - 2026
DA  - 2026/10/23
PB  - medRxiv
DO  - 10.64898/2026.10.23.26366241
UR  - https://www.medrxiv.org/content/10.64898/2026.10.23.26366241v1
AB  - A previously developed static compartment model informed influenza program decisions by estimating the direct impact of influenza vaccination. To improve the estimation of the burden averted by vaccination, we extended this model to consider multiple influenza seasons, allow natural and vaccine-induced immunity to wane over time allow influenza vaccine effectiveness (VE) to differ by hospitalized versus non-hospitalized influenza-associated illness, and measure deaths averted. For model demonstration, we created a synthetic Northern Hemisphere-like and year-round influenza activity dataset spanning four seasons among older adults (>65 years) and assumed VE against symptomatic illness of 37% (17%-53%) and VE against hospitalization of 45% (28%-59%). Under Northern Hemisphere-like activity and an existing vaccination program with an average annual vaccine coverage of 33%, vaccination averted 15.1% (95% UI: 12.2%-16.3%) of influenza-associated illnesses across four seasons; the annual prevented fraction for hospitalized deaths ranged from 14.4% (95% UI: 11.7%-16.8%) to 18.5% (95% UI: 14.9%-21.5%). Under a hypothetical year round vaccination program with an annual coverage of 20%, vaccination averted 4.9% (95% UI: 3.8%-5.4%) of influenza-associated illnesses across four seasons; the annual prevented fraction for hospitalized deaths ranged from 5.5% (95% UI: 4.3%-6.5%) and 5.8% (95% UI: 4.8%-6.6%). These model extensions allow estimation of vaccine-averted burden across multiple seasons and diverse vaccination program settings, providing information to support influenza vaccination decision-making.
ER  -